The state of Alabama is now one of 44 states to file a lawsuit against 20 major drug manufacturers that are accused of manipulating prices for more than 100 generic drugs. The complaint states that several of the drug manufacturers schemed to increase prices affecting Medicare and Medicaid, the health insurance market and individuals. 15 senior executive defendants responsible for sales, marketing, pricing, and operations were also named in the lawsuit.
The drugs affected included treatment for cancer, HIV, depression, diabetes and more. According to the lawsuit led by the state of Connecticut’s Attorney General, prices were sometimes raised by 1,000% on more than 80 drugs between July 2013 and January 2015. The multi-billion dollar lawsuit seeks damages, civil penalties and court actions to restore competition to the generic drug market.